Fibrinogen proteolysis and coagulation system activation during thrombolytic therapy.
Owen
J
J
Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC.
Grossman
B
B
Sobel
J
J
Kudryk
B
B
D004311:Double-Blind Method; D005340:Fibrinogen / Q000032:analysis; D005344:Fibrinopeptide A / Q000032:analysis; D005345:Fibrinopeptide B / Q000032:analysis; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D011994:Recombinant Proteins; D005344:Fibrinopeptide A; D005345:Fibrinopeptide B; D005340:Fibrinogen; D013300:Streptokinase; D010959:Tissue Plasminogen Activator